Epstein-Barr virus reactivation in renal transplant recipients.
S Afr Med J
; 71(6): 347-51, 1987 Mar 21.
Article
en En
| MEDLINE
| ID: mdl-3031832
ABSTRACT
Renal transplant recipients at Tygerberg Hospital were investigated to determine the importance of Epstein-Barr virus (EBV) as a pathogen in these patients. All 106 patients investigated were shown to have EBV antibodies before transplantation and most had serological evidence of reactivation of the infection after transplantation. A mild clinical illness was present in a few patients concomitant with EBV reactivation, which may suggest that this virus has a role in the morbidity of some renal transplant recipients. Lymphoblastoid cell lines were established from 11 renal transplant recipients; 5 of these cell lines were shown to be virus producers and 1 is thought to have unique properties.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Activación Viral
/
Trasplante de Riñón
/
Herpesvirus Humano 4
Límite:
Humans
Idioma:
En
Año:
1987
Tipo del documento:
Article